To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece

CompletedOBSERVATIONAL

Enrollment

180

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Growth Disorders

Interventions

DEVICE

Easypod™

Saizen (Somatotropin) as per Summary of Product Characteristics administered by Easypod™

Trial Locations (1)

For Recruiting Locations in Greece,, Please Contact the Merck KGaA Communication Center

All Listed Sponsors

collaborator

Merck A.E., Greece

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01363674 - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece | Biotech Hunter | Biotech Hunter